Company intelligence / Profile preview
Peptilogics
Pittsburgh, Pennsylvania, United Statespeptilogics.com ↗
- Ownership
- Private
- Employees
- ~30
- Development stage
- Phase 1
01
Overview
Peptilogics has advanced its lead candidate, PLG0206—a novel broad-spectrum anti-infective peptide—into clinical trials for prosthetic joint infection. The company leverages its proprietary Nautilus™ AI platform to accelerate the discovery and optimization of new peptide therapeutics targeting challenging diseases. No detailed published clinical results are available in the provided sources.
- Therapeutic areas
- OtherInfectious Diseases
- Modalities
- Peptide therapeuticsAI-driven peptide design
- Industry
- Biotech
02
Drug pipeline
6 assets5 more assets in the full pipeline.
03
Partnerships
Orion Biotechnology (strategic research collaboration on GPCR drug discovery using AI platforms)
Beyond the preview
Go deeper on Peptilogics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Peptilogics.